Facebook is no friend to pharma

KEY TAKEAWAY: According to the Times “If I were a Facebook executive, I might feel a Frankensteinian sense of unease these days. The company has been hit with a series of scandals that have bruised its image, enraged its critics and opened up the possibility that in its quest for global dominance, Facebook may have created something it can’t fully control.”  And they want pharma to advertise more?

[inlinetweet prefix=”” tweeter=”” suffix=””]As CEO of Facebook Mr. Zuckerberg’s modus operandi as a leader is to fix things long after they have broken[/inlinetweet], rather than to prevent problems in the first place.  For pharma that’s a major issue.

This is an ad that I keep seeing on Facebook as I was doing some research for a client.  I did an analysis of the comments and 85% were negative.  If I was a DTC manager or media buyer I would not proceed to give more money to the this monster.

Facebook has become some huge and profitable that they feel they can do no wrong.  They don’t have enough people with industry experience and their continued efforts to court pharma ad dollars is almost insulting.

Obviously Xarelto has risks, like any prescription drug, but [inlinetweet prefix=”” tweeter=”” suffix=””]hosting ads for ambulance chasers who profit off patient woes is is not a platform I would ever recommend to clients.[/inlinetweet]